These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 19664929
1. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics. Li HQ, Shi L, Li QS, Liu PG, Luo Y, Zhao J, Zhu HL. Bioorg Med Chem; 2009 Sep 01; 17(17):6264-9. PubMed ID: 19664929 [Abstract] [Full Text] [Related]
2. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Li HQ, Luo Y, Zhu HL. Bioorg Med Chem; 2011 Aug 01; 19(15):4454-9. PubMed ID: 21742506 [Abstract] [Full Text] [Related]
3. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Ashek A, Cho SJ. Bioorg Med Chem; 2006 Mar 01; 14(5):1474-82. PubMed ID: 16275103 [Abstract] [Full Text] [Related]
4. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors. Lv PC, Sun J, Luo Y, Yang Y, Zhu HL. Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4657-60. PubMed ID: 20594840 [Abstract] [Full Text] [Related]
5. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents. Shi L, Fang RQ, Zhu ZW, Yang Y, Cheng K, Zhong WQ, Zhu HL. Eur J Med Chem; 2010 Sep 01; 45(9):4358-64. PubMed ID: 20557983 [Abstract] [Full Text] [Related]
6. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors. Lv PC, Wang KR, Yang Y, Mao WJ, Chen J, Xiong J, Zhu HL. Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6750-4. PubMed ID: 19836235 [Abstract] [Full Text] [Related]
8. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents. Zhou Y, Du QR, Sun J, Li JR, Fang F, Li DD, Qian Y, Gong HB, Zhao J, Zhu HL. ChemMedChem; 2013 Mar 01; 8(3):433-41. PubMed ID: 23401291 [Abstract] [Full Text] [Related]
11. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents. Nie Z, Perretta C, Lu J, Su Y, Margosiak S, Gajiwala KS, Cortez J, Nikulin V, Yager KM, Appelt K, Chu S. J Med Chem; 2005 Mar 10; 48(5):1596-609. PubMed ID: 15743201 [Abstract] [Full Text] [Related]
14. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory. Zhang F, Wen Q, Wang SF, Shahla Karim B, Yang YS, Liu JJ, Zhang WM, Zhu HL. Bioorg Med Chem Lett; 2014 Jan 01; 24(1):90-5. PubMed ID: 24332628 [Abstract] [Full Text] [Related]
15. Novel E. coli beta-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics. Lee JY, Jeong KW, Lee JU, Kang DI, Kim Y. Bioorg Med Chem; 2009 Feb 15; 17(4):1506-13. PubMed ID: 19185501 [Abstract] [Full Text] [Related]
18. Synthesis and antibacterial activity of cinnamaldehyde acylhydrazone with a 1,4-benzodioxan fragment as a novel class of potent β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitor. Song X, Yang Y, Zhao J, Chen Y. Chem Pharm Bull (Tokyo); 2014 Feb 15; 62(11):1110-8. PubMed ID: 25196128 [Abstract] [Full Text] [Related]